Novo Nordisk Pharmaceuticals
The Novo Nordisk expansion project included the addition of two final assembly lines, two packing lines and building refurbishment. Novo Nordisk is the leading manufacturer in diabetes pharmaceuticals in the country and the Clayton facility is the company’s only insulin manufacturing facility in the US.